Results 231 to 240 of about 231,974 (295)

Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. [PDF]

Cancer Sci
Zhang X, Lan R, Li D, Liu Y, Kalyan S, Iqbal M, Liu N, Zhang J, Hanna I, Gupta M, Zhao CL, Liu W, Melamed J, Shusterman M, Widmer J, Allendorf J, Liu YZ.   +16 more
europepmc   +1 more source

Chemotherapy for Older Adults with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Shin DW, Ahn JS, Song H, Moon SH, Lee JC.   +4 more
europepmc   +1 more source

Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma. [PDF]

Genome Med
Villoslada-Blanco P, Alonso L, Sabroso-Lasa S, Maquedano M, Estudillo L, Real FX, López de Maturana E, Malats N.   +7 more
europepmc   +1 more source

Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug. [PDF]

Proc Natl Acad Sci U S A
Antonucci L, Watari K, Feng Y, Qi J, Zhu M, Wang T, Ng I, Vucic EA, Riahi I, Huang L, Hosseini M, Mose E, French R, Weitz J, Bar-Sagi D, Dawson DW, Sun B, Tiriac H, Xu J, Xu S, Lowy AM, Karin M.   +21 more
europepmc   +1 more source

Correction: UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. [PDF]

J Exp Clin Cancer Res
Chen H, Li L, Hu J, Zhao Z, Ji L, Cheng C, Zhang G, Zhang T, Li Y, Chen H, Pan S, Sun B.   +11 more
europepmc   +1 more source

Clinically aggressive early-onset pancreatic ductal adenocarcinoma with KRAS wild-type status: A case report. [PDF]

Biomed Rep
Avendaño ME, San Martin Abello C, Gómez-Valenzuela F, Silva I, Retamal IN, García-Bloj B, De Mayo Glaser T, Muñoz-Medel M, Gómez A, Sánchez C, Pinto F, Aravena P, Sabioncello AC, Garrido Villanueva M, Sigler Chávez F, Corvalán I, Barrios H, Sáez MA, Erpel JM, Manque PA, Rios JA, Godoy JA, Garrido M.   +22 more
europepmc   +1 more source

TBC1D23 drives lymphatic metastasis in pancreatic ductal adenocarcinoma by altering EGFR cell surface dynamics and signaling. [PDF]

Cell Oncol (Dordr)
Chao YJ, Wang HC, Chen YL, Wang CJ, Hou YC, Kuo YT, Shin JW, Shan YS.   +7 more
europepmc   +1 more source

Computational Modeling of Cellular Influence Delineates Functionally Relevant and Distinct Cellular Neighborhoods in Primary and Metastatic Pancreatic Ductal Adenocarcinoma. [PDF]

Cancer Immunol Res
Cho Y, Lee JW, Shin SM, Hernandez AG, Yuan X, Schneider J, Hooper JE, Wood LD, Jaffee EM, Deshpande A, Ho WJ.   +10 more
europepmc   +1 more source